List of Tables
Table 1. Lung Cancer Liquid Biopsy Market Trends
Table 2. Lung Cancer Liquid Biopsy Market Drivers & Opportunity
Table 3. Lung Cancer Liquid Biopsy Market Challenges
Table 4. Lung Cancer Liquid Biopsy Market Restraints
Table 5. Global Lung Cancer Liquid Biopsy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lung Cancer Liquid Biopsy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Lung Cancer Liquid Biopsy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Lung Cancer Liquid Biopsy Product Type
Table 9. Key Companies Time to Begin Mass Production of Lung Cancer Liquid Biopsy
Table 10. Global Lung Cancer Liquid Biopsy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Lung Cancer Liquid Biopsy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Lung Cancer Liquid Biopsy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Lung Cancer Liquid Biopsy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Lung Cancer Liquid Biopsy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Lung Cancer Liquid Biopsy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Lung Cancer Liquid Biopsy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Lung Cancer Liquid Biopsy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Lung Cancer Liquid Biopsy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Lung Cancer Liquid Biopsy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Lung Cancer Liquid Biopsy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Lung Cancer Liquid Biopsy Sales Value by Region (2019-2024) & (%)
Table 27. Global Lung Cancer Liquid Biopsy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value, (2025-2030) & (US$ Million)
Table 31. RainDanceTechnologies Basic Information List
Table 32. RainDanceTechnologies Description and Business Overview
Table 33. RainDanceTechnologies Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of RainDanceTechnologies (2019-2024)
Table 35. RainDanceTechnologies Recent Developments
Table 36. Biocartis Basic Information List
Table 37. Biocartis Description and Business Overview
Table 38. Biocartis Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Biocartis (2019-2024)
Table 40. Biocartis Recent Developments
Table 41. Qiagen Basic Information List
Table 42. Qiagen Description and Business Overview
Table 43. Qiagen Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Qiagen (2019-2024)
Table 45. Qiagen Recent Developments
Table 46. Guardant Health Basic Information List
Table 47. Guardant Health Description and Business Overview
Table 48. Guardant Health Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Guardant Health (2019-2024)
Table 50. Guardant Health Recent Developments
Table 51. MDxHealth Basic Information List
Table 52. MDxHealth Description and Business Overview
Table 53. MDxHealth Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of MDxHealth (2019-2024)
Table 55. MDxHealth Recent Developments
Table 56. Pathway Genomics Basic Information List
Table 57. Pathway Genomics Description and Business Overview
Table 58. Pathway Genomics Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Pathway Genomics (2019-2024)
Table 60. Pathway Genomics Recent Developments
Table 61. NeoGenomics Laboraories Basic Information List
Table 62. NeoGenomics Laboraories Description and Business Overview
Table 63. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of NeoGenomics Laboraories (2019-2024)
Table 65. NeoGenomics Laboraories Recent Developments
Table 66. Sysmex Inostics Basic Information List
Table 67. Sysmex Inostics Description and Business Overview
Table 68. Sysmex Inostics Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Sysmex Inostics (2019-2024)
Table 70. Sysmex Inostics Recent Developments
Table 71. Cynvenio Basic Information List
Table 72. Cynvenio Description and Business Overview
Table 73. Cynvenio Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Cynvenio (2019-2024)
Table 75. Cynvenio Recent Developments
Table 76. Menarini Silicon Biosystems Basic Information List
Table 77. Menarini Silicon Biosystems Description and Business Overview
Table 78. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Menarini Silicon Biosystems (2019-2024)
Table 80. Menarini Silicon Biosystems Recent Developments
Table 81. Adaptive Biotechnologies Basic Information List
Table 82. Adaptive Biotechnologies Description and Business Overview
Table 83. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Adaptive Biotechnologies (2019-2024)
Table 85. Adaptive Biotechnologies Recent Developments
Table 86. Biocept Basic Information List
Table 87. Biocept Description and Business Overview
Table 88. Biocept Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Biocept (2019-2024)
Table 90. Biocept Recent Developments
Table 91. Angle plc Basic Information List
Table 92. Angle plc Description and Business Overview
Table 93. Angle plc Lung Cancer Liquid Biopsy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Lung Cancer Liquid Biopsy Business of Angle plc (2019-2024)
Table 95. Angle plc Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Lung Cancer Liquid Biopsy Downstream Customers
Table 99. Lung Cancer Liquid Biopsy Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Lung Cancer Liquid Biopsy Product Picture
Figure 2. Global Lung Cancer Liquid Biopsy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 4. Lung Cancer Liquid Biopsy Report Years Considered
Figure 5. Global Lung Cancer Liquid Biopsy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Cancer Liquid Biopsy Revenue in 2023
Figure 7. Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Exosomes and RNA Picture
Figure 9. CTCs and ctDNA Picture
Figure 10. Global Lung Cancer Liquid Biopsy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Lung Cancer Liquid Biopsy Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals
Figure 13. Product Picture of Clinics
Figure 14. Product Picture of Others
Figure 15. Global Lung Cancer Liquid Biopsy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Lung Cancer Liquid Biopsy Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Lung Cancer Liquid Biopsy Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Lung Cancer Liquid Biopsy Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Lung Cancer Liquid Biopsy Sales Value (%), (2019-2030)
Figure 28. United States Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 34. China Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 36. China Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 46. India Lung Cancer Liquid Biopsy Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Lung Cancer Liquid Biopsy Sales Value by Type (%), 2023 VS 2030
Figure 48. India Lung Cancer Liquid Biopsy Sales Value by Application (%), 2023 VS 2030
Figure 49. Lung Cancer Liquid Biopsy Industrial Chain
Figure 50. Lung Cancer Liquid Biopsy Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
